ContractDevelopment and Commercialisation Agreement • September 29th, 2014 • Dermira, Inc. • Pharmaceutical preparations • New York
[*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
DEVELOPMENT AND COMMERCIALISATION AGREEMENTDevelopment and Commercialisation Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • Ontario
THIS DEVELOPMENT AND COMMERCIALISATION AGREEMENT (this "Agreement") is made and entered into as of February 28, 2011 (the "Effective Date"), by and between IntelGenx Corp., a Canadian corporation ("lntelGenx"), and Pacific Therapeutics Ltd., a Canadian company ("Pacific"). IntelGenx and Pacific each may be referred to herein individually as a "Party," or collectively as the "Parties".
Exhibit 3.2(y) "CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT IDENTIFIED BY *** HAVE BEEN OMITTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED...Development and Commercialisation Agreement • December 19th, 2005 • Chemgenex Pharmaceuticals LTD • Pharmaceutical preparations
DEVELOPMENT AND COMMERCIALISATION AGREEMENTDevelopment and Commercialisation Agreement • April 30th, 2014 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
THIS DEVELOPMENT AND COMMERCIALISATION AGREEMENT (this "Agreement") is made and entered into as of October 22, 2013 (the "Effective Date"), by and between Globe Labs Inc., a Canadian corporation ("Globe"), and Pacific Therapeutics Ltd., a Canadian company ("Pacific"). Globe and Pacific each may be referred to herein individually as a "Party," or collectively as the "Parties".
